- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- monomer
- Ligands
- 1 x FU9: 3-(cyclopropylamino)-5-{[3-(trifluoromethyl)phenyl]amino}pyrimido[4,5-c]quinoline-8-carboxylic acid(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: R.80, R.155, N.189, V.192
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.189
- Water bridges: A:R.155, A:E.180, A:N.189
- Salt bridges: A:R.80, A:R.155
SO4.3: 4 residues within 4Å:- Chain A: R.191, K.198, N.238
- Ligands: PEG.6
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.238, A:N.238
- Salt bridges: A:R.191, A:K.198
SO4.4: 5 residues within 4Å:- Chain A: D.253, R.278, R.306, Y.307, D.308
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:Y.307, A:D.308
- Water bridges: A:D.253, A:R.306, A:R.306
- Salt bridges: A:R.278, A:R.306
SO4.5: 3 residues within 4Å:- Chain A: N.93, K.170, R.172
3 PLIP interactions:3 interactions with chain A- Water bridges: A:N.93, A:N.93
- Salt bridges: A:R.172
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 6 residues within 4Å:- Chain A: Q.36, Y.39, L.41, V.101, D.103, P.104
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.36, A:Y.39
EDO.8: 6 residues within 4Å:- Chain A: N.118, D.120, H.160
- Ligands: FU9.1, EDO.11, EDO.14
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.118, A:H.160
- Water bridges: A:H.160
EDO.9: 1 residues within 4Å:- Chain A: D.37
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.37
EDO.10: 5 residues within 4Å:- Chain A: K.229, F.232, F.233, V.248, F.284
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.244
EDO.11: 9 residues within 4Å:- Chain A: N.118, T.119, D.120, F.121, P.159, V.162, M.163, I.164
- Ligands: EDO.8
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.118, A:T.119, A:F.121, A:P.159, A:I.164, A:I.164
EDO.12: 5 residues within 4Å:- Chain A: K.158, H.160, S.194
- Ligands: PEG.6, EDO.13
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.194
- Water bridges: A:K.158
EDO.13: 5 residues within 4Å:- Chain A: F.121, P.159, F.197, E.230
- Ligands: EDO.12
No protein-ligand interaction detected (PLIP)EDO.14: 3 residues within 4Å:- Chain A: N.118
- Ligands: FU9.1, EDO.8
No protein-ligand interaction detected (PLIP)EDO.15: 5 residues within 4Å:- Chain A: R.278, K.279, W.281, D.302, R.306
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.302, A:R.306
- Water bridges: A:D.302
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Battistutta, R. et al., Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer. Biochemistry (2011)
- Release Date
- 2011-12-07
- Peptides
- Casein kinase II subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- monomer
- Ligands
- 1 x FU9: 3-(cyclopropylamino)-5-{[3-(trifluoromethyl)phenyl]amino}pyrimido[4,5-c]quinoline-8-carboxylic acid(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Battistutta, R. et al., Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer. Biochemistry (2011)
- Release Date
- 2011-12-07
- Peptides
- Casein kinase II subunit alpha: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A